Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study.

Published May 27, 2023 | Version v1

Journal article Open

The documents are all supplementary files concerning a paper describing the safety and efficacy of a class II medical devise in GSE.

Files

Name	Size
Supplementary File 1.pdf md5:cd2e957894e25ff9fa0e373ff32b374f	49.7 kB	Preview Download
Supplementary File 2.pdf md5:2df26d22e9f4021372e37636bfb86f6d	221.7 kB	Preview Download
Supplementary File 3.pdf md5:aee0b8ccc90a8e09616dee6cd58fa2e2	380.9 kB	Preview Download
Supplementary File 4.pdf md5:8358447977f7b32efddbc11307741418	299.6 kB	Preview Download
Supplementary File 5.pdf md5:25eb082ef026817c7b10102277422948	837.0 kB	Preview Download

Is published in: https://www.ulprospector.com/en/eu/PersonalCare/Detail/2736/81971/Zanthalene (URL)

Views

324

Downloads

Show more details

DOI

Resource type

Journal article

Publisher

Zenodo

Published in

Int J Mol Sci, 2023.

License: Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more